Placeholder

Could your current biopsy option be missing a lurking threat?

Accurate and timely diagnosis is key for women and their futures1,2

Vacuum-assisted biopsy (VAB) and breast tissue markers Vacuum-assisted excision (VAE)

Breast cancer represents a significant burden for women:3-5

Clipboard icon

The leading cancer diagnosis in women3


Woman icon

The leading cause of cancer-related death in women4


Global icon

The 4th most common cause of cancer-related mortality globally5


A deeper look reveals the truth about breast cancer

Projections also indicate that breast cancer incidence and mortality is going to rise significantly.

Percentage 38% icon
By 2050, cases are expected to increase by 38% globally6

Percentage 68% icon
By 2050, deaths are expected to increase by 68% globally6


Check mark icon

Early and accurate diagnosis paired with effective management is the best chance patients with breast cancer have of successful treatment.1,2,7


Choosing the right biopsy approach for breast health patients isn't always easy. While the benefits of core needle biopsy (CNB) and surgical excision are well established, they can also be associated with the threat of false negative results or avoidable surgical risks.8,9

It's why this website is dedicated to providing practical educational information on vacuum-assisted biopsy (VAB), vacuum-assisted excision (VAE), and breast tissue markers. By considering these methods alongside traditional approaches, such as CNB or surgical excision, you can assess which biopsy method is best suited to your breast health patients' individual needs.

Deepen your understanding by exploring the resources below.

Vacuum-assisted biopsy (VAB)

Maxmise your chances of achieving reliable results for patients first time.

  • Reduces the risk of false negatives*10,11
  • Reduces the need for re-biopsy*11,12
  • Results in less or equivalent pain for your patients during and after procedures*10,13

Prioritise your patient's breast treatment journey today.

Learn more about VAB

*When compared with CNB


VAB for a patient with a hypoechoic, 10 mm breast nodule.


Patient with a breast fibroadenoma confirmed by core biopsy three years prior, receiving VAE due to increase in size from 11 mm to 23 mm.

Vacuum-assisted excision (VAE)

A minimally-invasive alternative to surgery

  • No compromise on efficacy14-16
  • A high complete resection rate, from 70 - 100%15,17-19
  • Appropriate for a range of lesions, including B3 lesions and high-risk lesions, and benign lesions such as fibroadenomas14-18,20

Protect your patients from the sting of avoidable surgical risks today.

Learn more about VAE

Breast tissue markers

Improved precision across long-term care

  • Helps assess tumour size21
  • Differentiates between multiple lesions21
  • Improves precision during surgery21
  • Enhances long-term care, monitoring and follow-up22-24

Have confidence in your breast diagnostic accuracy and precision today.

Learn more about breast tissue markers


Breast tissue marker placement in a patient receiving a biopsy for a heterogenous, 20 mm breast nodule.

Explore our resources to learn more

BD EleVation™ resource

Mammography-guided breast interventions video

Let's have a conversation